Physician profile
Min Cen
NPI 1275068801
$518.20
in general payments reported to CMS, 2019-2025
8 companies · $256 in 2025
The $256 reported for 2025 was more than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $142 · 2023: $58.67 · 2024: $61.40 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $376.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Luye Pharma (USA) Ltd. | $185.59 | 2025 | Erzofri Extended-Release |
| Bayer Healthcare Pharmaceuticals INC. | $139.33 | 2022-2023 | |
| Abbvie INC. | $82.01 | 2024-2025 | |
| Novo Nordisk INC | $27.22 | 2024 | Wegovy |
| Merck Sharp & Dohme LLC | $23.28 | 2023 | Vaxelis, Gardasil 9, Vaxneuvance |
| Alkermes, INC. | $22.93 | 2025 | Aristada, Lybalvi |
| Sanofi Pasteur INC. | $18.95 | 2022 | |
| Glaxosmithkline, LLC. | $18.89 | 2023 | Pediarix, Shingrix, Bexsero |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Min Cen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.